The mutations of the cysteine-rich domain in RET is frequently shown in multiple endocrine neoplasia type 2A (MEN2A) or familial medullary thyroid carcinoma (FMTC) [5]. Here, RET is linked to multiple endocrine neoplasia type 2A.